{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:19:23Z","timestamp":1790968763079,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05327-7","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:34:25Z","timestamp":1766147665000},"page":"3563-3572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CT-derived tumor extracellular volume fraction for predicting recurrence in non-muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"5327_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"5327_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","volume":"76","author":"M Babjuk","year":"2019","unstructured":"Babjuk M, Burger M, Comp\u00e9rat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Roupr\u00eat M, Shariat SF, Sylvester R, Zigeuner R (2019) European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) \u2013 2019 update. Eur Urol 76:639\u2013657. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.016","journal-title":"Eur Urol"},{"key":"5327_CR3","doi-asserted-by":"publisher","first-page":"e35966","DOI":"10.1002\/cncr.35966","volume":"131","author":"A Lazarovich","year":"2025","unstructured":"Lazarovich A, Sweis RF (2025) The current and future role of systemic therapy in non-muscle-invasive bladder cancer. Cancer 131:e35966. https:\/\/doi.org\/10.1002\/cncr.35966","journal-title":"Cancer"},{"key":"5327_CR4","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pi\u00f1eiro L, Gonzalez M, Portillo J, Ojea A, Pertusa C, Rodriguez-Molina J, Camacho JE, Rabadan M, Astobieta A, Montesinos M, Isorna S, Munta\u00f1ola P, Gimeno A, Blas M, Martinez-Pi\u00f1eiro JA (2009) Predicting non-muscle-invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette\u2013Gu\u00e9rin: the CUETO scoring model. J Urol 182:2195\u20132203. https:\/\/doi.org\/10.1016\/j.juro.2009.07.016","journal-title":"J Urol"},{"key":"5327_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DWW, Kurth K, Vedder MM, M\u00e1rquez M, de Bekker-Grob EW, Calster BV, van der Schoot DKF, Lingsma HF, Bangma CH, Steyerberg EW, Zuithoff NPA, Kiemeney L, van Rhijn BWG (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013477. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031","journal-title":"Eur Urol"},{"key":"5327_CR6","doi-asserted-by":"publisher","first-page":"e96849","DOI":"10.1371\/journal.pone.0096849","volume":"9","author":"MM Vedder","year":"2014","unstructured":"Vedder MM, M\u00e1rquez M, de Bekker-Grob EW, Calster BV, van der Schoot DKF, Lingsma HF, Bangma CH, Steyerberg EW, Zuithoff NPA, Kiemeney L, van Rhijn BWG (2014) Risk predictionscores for recurrence and progression of non-muscle-invasive bladder cancer: aninternational validation in primary tumours. PLoS One 9:e96849. https:\/\/doi.org\/10.1371\/journal.pone.0096849","journal-title":"PLoS One"},{"key":"5327_CR7","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/bjc.2013.372","volume":"109","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Kent M, Kluth L, Pycha A, Comploj E, Svatek RS, Lotan Y, Seitz C, Karakiewicz PI, Fisch M, Rieken M, Daneshmand S (2013) Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder. Br J Cancer 109:1460\u20131466. https:\/\/doi.org\/10.1038\/bjc.2013.372","journal-title":"Br J Cancer"},{"key":"5327_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, Du Q, Wang J, Zhang W, Jiang B, Lin L, Xu G, Liu Q (2023) Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis 14:587. https:\/\/doi.org\/10.1038\/s41419-023-06110-6","journal-title":"Cell Death Dis"},{"key":"5327_CR9","doi-asserted-by":"publisher","first-page":"68954","DOI":"10.18632\/oncotarget.12135","volume":"7","author":"J Wu","year":"2016","unstructured":"Wu J, Liang C, Chen M, Su W (2016) Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis. Oncotarget 7:68954\u201368965. https:\/\/doi.org\/10.18632\/oncotarget.12135","journal-title":"Oncotarget"},{"key":"5327_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13244-024-01689-6","volume":"15","author":"W Cai","year":"2024","unstructured":"Cai W, Zhu Y, Teng Z, Wang L, Li J, Wu H, Song B (2024) Extracellular volume-based scoring system for tracking tumor progression in pancreatic cancer patients receiving intraoperative radiotherapy. Insights Imaging 15:116. https:\/\/doi.org\/10.1186\/s13244-024-01689-6","journal-title":"Insights Imaging"},{"key":"5327_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00330-024-10737-0","volume":"35","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jiang J, Yan C, Liu H, Wang Y, Wang L, Li Y, Liang C, Jin Z, Yu H (2025) Prediction of tumor regression grade in far-advanced gastric cancer after preoperative immuno-chemotherapy using dual-energy CT-derived extracellular volume fraction. Eur Radiol 35:93\u2013104. https:\/\/doi.org\/10.1007\/s00330-024-10737-0","journal-title":"Eur Radiol"},{"key":"5327_CR12","doi-asserted-by":"publisher","first-page":"2534856","DOI":"10.1080\/07853890.2025.2534856","volume":"57","author":"W Liu","year":"2025","unstructured":"Liu W, Guo Y, Gong B, Li C, Zhang Y, Li H, Li X, Zhang X (2025) Extracellular volume fraction quantification by equilibrium contrast-enhanced CT via automated segmentation predicts survival outcomes in bladder cancer: a propensity score-matched study. Ann Med 57:2534856. https:\/\/doi.org\/10.1080\/07853890.2025.2534856","journal-title":"Ann Med"},{"key":"5327_CR13","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","volume":"163","author":"DL Lamm","year":"2000","unstructured":"Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED (2000) Maintenance bacillus Calmette\u2013Gu\u00e9rin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study. J Urol 163:1124\u20131129.","journal-title":"J Urol"},{"key":"5327_CR14","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"RJ Sylvester","year":"2010","unstructured":"Sylvester RJ, Brausi MA, Kirkels WJ, Hoeltl W, Calais Da Silva F, Powell PH, Prescott S, Kirkali Z, van de Beek C, Gorlia T, de Reijke TM (2010) Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette\u2013Gu\u00e9rin, and bacillus Calmette\u2013Gu\u00e9rin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 57:766\u2013773. https:\/\/doi.org\/10.1016\/j.eururo.2009.12.024","journal-title":"Eur Urol"},{"key":"5327_CR15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"5327_CR16","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1007\/s00330-022-09307-z","volume":"33","author":"Y Luo","year":"2023","unstructured":"Luo Y, Liu L, Liu D, Zeng M, Li W, Li B, Wang Y (2023) Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Eur Radiol 33:4042\u20134051. https:\/\/doi.org\/10.1007\/s00330-022-09307-z","journal-title":"Eur Radiol"},{"key":"5327_CR17","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00330-019-06517-w","volume":"30","author":"Y Fukukura","year":"2020","unstructured":"Fukukura Y, Kumagae Y, Higashi R, Hakamada H, Fujiyoshi F, Takumi K (2020) Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma. Eur Radiol 30:1679\u20131689. https:\/\/doi.org\/10.1007\/s00330-019-06517-w","journal-title":"Eur Radiol"},{"key":"5327_CR18","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1186\/s13244-024-01929-6","volume":"32","author":"Y Peng","year":"2022","unstructured":"Peng Y, Shen H, Tang H, Xu F, Mai Z, Li X, Xie X, Kuang M, Wang Y, Chen L, Xu L, Zhang X, Zhang J, Bai X, Peng Q, Guo E, Lu X, Yu S, Jin Z, Zhang G, Xie Y, Xue H, Sun H (2022) omogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma. Eur Radiol 32:8529\u20138539. https:\/\/doi.org\/10.1186\/s13244-024-01929-6","journal-title":"Eur Radiol"},{"key":"5327_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13244-024-01929-6","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen L, Xu L, Zhang X, Zhang J, Bai X, Peng Q, Guo E, Lu X, Yu S, Jin Z, Zhang G, Xie Y, Xue H, Sun H (2025) Diagnostic value of dual-layer spectral detector CT parameters for differentiating high- from low-grade bladder cancer. Insights Imaging 16:6. https:\/\/doi.org\/10.1186\/s13244-024-01929-6","journal-title":"Insights Imaging"},{"key":"5327_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15:786\u2013801. https:\/\/doi.org\/10.1038\/nrm3904","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5327_CR21","doi-asserted-by":"publisher","first-page":"13643","DOI":"10.1038\/s41598-025-97677-x","volume":"15","author":"X Fu","year":"2025","unstructured":"Fu X, Guo Y, Zhang K, Li C, Li H, Li X, Zhang X (2025) Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors. Sci Rep 15:13643. https:\/\/doi.org\/10.1038\/s41598-025-97677-x","journal-title":"Sci Rep"},{"key":"5327_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","volume":"12","author":"B Doshi","year":"2023","unstructured":"Doshi B, Athans SR, Woloszynska A, Koshkin VS (2023) Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions. Oncogenesis 12:44. https:\/\/doi.org\/10.1038\/s41389-023-00489-9","journal-title":"Oncogenesis"},{"key":"5327_CR23","first-page":"105","volume":"8","author":"I Jansen","year":"2020","unstructured":"Jansen I, van Leeuwen TG, Marquering HA, de Bruin DM, Oddens JR (2020) Association of tumour location and recurrence in patients with non-muscle-invasive bladder cancer. EMJ Oncol 8:105\u2013113.","journal-title":"EMJ Oncol"},{"key":"5327_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JYY Teoh","year":"2022","unstructured":"Teoh JYY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M (2022) Recurrence mechanisms of non-muscle-invasive bladder cancer \u2013 a clinical perspective. Nat Rev Urol 19:280\u2013294. https:\/\/doi.org\/10.1038\/s41585-022-00578-1","journal-title":"Nat Rev Urol"},{"key":"5327_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4103\/0970-1591.166446","volume":"31","author":"SP Porten","year":"2015","unstructured":"Porten SP, Leapman MS, Greene KL (2015) Intravesical chemotherapy in non-muscle-invasive bladder cancer. Indian J Urol 31:297\u2013303. https:\/\/doi.org\/10.4103\/0970-1591.166446","journal-title":"Indian J Urol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05327-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05327-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05327-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:43:40Z","timestamp":1781498620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05327-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5327"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05327-7","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}